The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy

PURPOSE: To evaluate the effect of intravitreal bevacizumab injection (IVBI) in acute central serous chorioretinopathy (CSC) patients. METHODS: Patients with acute CSC received IVBI (1.25 mg/0.05 mL) or observation by randomization. Twelve eyes in each group completed 6 months of regular follow-up a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ji Won, Ryu, Su Jeong, Shin, Min Cheol
Formato: Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882078/
https://www.ncbi.nlm.nih.gov/pubmed/20532141
http://dx.doi.org/10.3341/kjo.2010.24.3.155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882078/
https://www.ncbi.nlm.nih.gov/pubmed/20532141
http://dx.doi.org/10.3341/kjo.2010.24.3.155

Ejemplares similares